Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/american-medical-association/diet-intervention-and-cerebrospinal-fluid-biomarkers-in-amnestic-mild-7bcF0eJ3TO
References (62)
-
T. Montine, E. Peskind, J. Quinn, Angela Wilson, K. Montine, D. Galasko (2011)
Increased Cerebrospinal Fluid F2-Isoprostanes are Associated with Aging and Latent Alzheimer’s Disease as Identified by BiomarkersNeuroMolecular Medicine, 13
-
Suzanne Wahrle, Hong Jiang, Maia Parsadanian, Jungsu Kim, Aimin Li, Amanda Knoten, S. Jain, Veronica Hirsch-Reinshagen, C. Wellington, K. Bales, S. Paul, D. Holtzman (2008)
Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease.The Journal of clinical investigation, 118 2
-
R. DeMattos, K. Bales, Maia Parsadanian, Mark O'dell, Eric Foss, S. Paul, D. Holtzman (2002)
Plaque‐associated disruption of CSF and plasma amyloid‐β (Aβ) equilibrium in a mouse model of Alzheimer's diseaseJournal of Neurochemistry, 81
-
D. Matthews, J. Hosker, A. Rudenski, B. Naylor, D. Treacher, R. Turner (1985)
Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 28
-
P. Whitehouse, H. Moody (2006)
Mild cognitive impairmentDementia, 5
-
S. Kanoski, T. Davidson (2011)
Western diet consumption and cognitive impairment: Links to hippocampal dysfunction and obesityPhysiology & Behavior, 103
-
M. Reger, G. Watson, P. Green, C. Wilkinson, L. Baker, B. Cholerton, M. Fishel, S. Plymate, J. Breitner, W. DeGroodt, P. Mehta, S. Craft (2008)
Intranasal insulin improves cognition and modulates β-amyloid in early ADNeurology, 70
-
Leila Shobab, G. Hsiung, H. Feldman (2005)
Cholesterol in Alzheimer's diseaseThe Lancet Neurology, 4
-
Joern Schroeder, J. Richardson, D. Virley (2010)
Dietary manipulation and caloric restriction in the development of mouse models relevant to neurological diseases.Biochimica et biophysica acta, 1802 10
-
Y. Kuo, M. Emmerling, C. Bisgaier, A. Essenburg, H. Lampert, Denise Drumm, A. Roher (1998)
Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels.Biochemical and biophysical research communications, 252 3
-
Y. Freund-Levi, M. Eriksdotter‐Jönhagen, T. Cederholm, H. Basun, G. Faxén-Irving, A. Garlind, I. Vedin, B. Vessby, L. Wahlund, J. Palmblad (2006)
Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.Archives of neurology, 63 10
-
S Craft, E Peskind, MW Schwartz, GD Schellenberg, M Raskind, D Porte (1998)
Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype., 50
-
Patty Siri-Tarino, Qi Sun, F. Hu, R. Krauss (2010)
Saturated fat, carbohydrate, and cardiovascular disease.The American journal of clinical nutrition, 91 3
-
S. Kim, F. Abbasi, G. Reaven (2004)
Impact of degree of obesity on surrogate estimates of insulin resistance.Diabetes care, 27 8
-
J. Mielke, C. Taghibiglou, Lidong Liu, Yu Zhang, Zhengping Jia, K. Adeli, Yu Wang (2005)
A biochemical and functional characterization of diet‐induced brain insulin resistanceJournal of Neurochemistry, 93
-
W. Friedewald, R. Levy, D. Fredrickson (1972)
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.Clinical chemistry, 18 6
-
S. Craft, J. Newcomer, S. Kanne, S. Dagogo-Jack, P. Cryer, Y. Sheline, J. Luby, Agbani Dagogo-Jack, A. Alderson (1996)
Memory improvement following induced hyperinsulinemia in alzheimer's diseaseNeurobiology of Aging, 17
-
J. Sonnen, J. Breitner, M. Lovell, W. Markesbery, J. Quinn, T. Montine (2008)
Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models.Free radical biology & medicine, 45 3
-
James Hill, H. Wyatt, G. Reed, J. Peters (2003)
Obesity and the Environment: Where Do We Go from Here?Science, 299
-
D. Praticò, C. Clark, Feyan Liun, J. Rokach, V. Lee, J. Trojanowski (2002)
Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease.Archives of neurology, 59 6
-
H. Englund, G. Annéren, J. Gustafsson, Ulrika Wester, J. Wiltfang, L. Lannfelt, K. Blennow, K. Höglund (2007)
Increase in β-Amyloid Levels in Cerebrospinal Fluid of Children with Down SyndromeDementia and Geriatric Cognitive Disorders, 24
-
C. Féart, C. Samieri, V. Rondeau, H. Amièva, F. Portet, J. Dartigues, N. Scarmeas, P. Barberger‐Gateau (2009)
Adherence to a Mediterranean diet, cognitive decline, and risk of dementia.JAMA, 302 6
-
V. Solfrizzi, V. Frisardi, C. Capurso, A. D'Introno, A. Colacicco, G. Vendemiale, A. Capurso, F. Panza (2010)
Dietary fatty acids in dementia and predementia syndromes: Epidemiological evidence and possible underlying mechanismsAgeing Research Reviews, 9
-
Lixia Zhao, B. Teter, T. Morihara, G. Lim, Surendra Ambegaokar, O. Ubeda, S. Frautschy, G. Cole (2004)
Insulin-Degrading Enzyme as a Downstream Target of Insulin Receptor Signaling Cascade: Implications for Alzheimer's Disease InterventionThe Journal of Neuroscience, 24
-
E. Stomrud, O. Hansson, H. Zetterberg, K. Blennow, L. Minthon, E. Londos (2010)
Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.Archives of neurology, 67 2
-
MA Reger, GS Watson, PS Green (2008)
Intranasal insulin improves cognition and modulates β-amyloid in early AD [published correction appears in Neurology. 2008;71(11):866]., 70
-
K. Kaiyala, R. Prigeon, S. Kahn, S. Woods, M. Schwartz (2000)
Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs.Diabetes, 49 9
-
C Féart, C Samieri, V Rondeau (2009)
Adherence to a Mediterranean diet, cognitive decline, and risk of dementia [published correction appears in JAMA. 2009;302(22):2436]., 302
-
F. Hu, R. Dam, Simin Liu (2001)
Diet and risk of Type II diabetes: the role of types of fat and carbohydrateDiabetologia, 44
-
T. Wolever, Ming Yang, X. Zeng, F. Atkinson, J. Brand-Miller (2006)
Food glycemic index, as given in glycemic index tables, is a significant determinant of glycemic responses elicited by composite breakfast meals.The American journal of clinical nutrition, 83 6
-
R. Benedict (2005)
Effects of using same- versus alternate-form memory tests during short-interval repeated assessments in multiple sclerosisJournal of the International Neuropsychological Society, 11
-
J. Sonnen, Eric Larson, Kiri Brickell, Paul Crane, Randall Woltjer, Thomas Montine, Suzanne Craft (2009)
Different patterns of cerebral injury in dementia with or without diabetes.Archives of neurology, 66 3
-
M. Mifflin, S. Jeor, Lisa Hill, B. Scott, Sandra Daugherty, Young Koh (1990)
A new predictive equation for resting energy expenditure in healthy individuals.The American journal of clinical nutrition, 51 2
-
E. Peskind, Ge Li, J. Shofer, J. Quinn, J. Kaye, C. Clark, M. Farlow, C. DeCarli, M. Raskind, G. Schellenberg, V. Lee, D. Galasko (2006)
Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition.Archives of neurology, 63 7
-
T. Tapiola, H. Soininen, T. Pirttilä (2001)
CSF tau and Aβ42 levels in patients with Down’s syndromeNeurology, 56
-
F. Felice, M. Vieira, Theresa Bomfim, H. Decker, P. Velasco, M. Lambert, K. Viola, Wei⁃qin Zhao, S. Ferreira, W. Klein (2009)
Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomersProceedings of the National Academy of Sciences, 106
-
P. Mehta, T. Pirttilä, S. Mehta, E. Sersen, P. Aisen, H. Wiśniewski (2000)
Plasma and cerebrospinal fluid Levels of amyloid β proteins 1-40 and 1-42 in Alzheimer diseaseJAMA Neurology, 57
-
L. Baker, L. Frank, K. Foster-Schubert, P. Green, C. Wilkinson, A. McTiernan, S. Plymate, Mark Fishel, G. Watson, B. Cholerton, G. Duncan, P. Mehta, S. Craft (2010)
Effects of aerobic exercise on mild cognitive impairment: a controlled trial.Archives of neurology, 67 1
-
R. Kalaria (2010)
Vascular basis for brain degeneration: faltering controls and risk factors for dementia.Nutrition reviews, 68 Suppl 2
-
R. Roberts, Y. Geda, D. Knopman, R. Cha, V. Pankratz, B. Boeve, R. Ivnik, E. Tangalos, R. Petersen, W. Rocca (2008)
The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample CharacteristicsNeuroepidemiology, 30
-
Li Liu, S. Herukka, R. Minkeviciene, T. Groen, H. Tanila (2004)
Longitudinal observation on CSF Aβ42 levels in young to middle-aged amyloid precursor protein/presenilin-1 doubly transgenic miceNeurobiology of Disease, 17
-
N. Scarmeas, Y. Stern, R. Mayeux, J. Manly, N. Schupf, J. Luchsinger (2009)
Mediterranean diet and mild cognitive impairment.Archives of neurology, 66 2
-
A. Fagan, M. Mintun, R. Mach, Sang-Yoon Lee, C. Dence, Aarti Shah, Gina LaRossa, Michael Spinner, W. Klunk, C. Mathis, S. DeKosky, J. Morris, D. Holtzman (2006)
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humansAnnals of Neurology, 59
-
S. Craft, E. Peskind, M. Schwartz, G. Schellenberg, M. Raskind, D. Porte (1998)
Cerebrospinal fluid and plasma insulin levels in Alzheimer's diseaseNeurology, 50
-
S. Cunnane, M. Plourde, F. Pifferi, M. Bēgin, C. Féart, P. Barberger‐Gateau (2009)
Fish, docosahexaenoic acid and Alzheimer's disease.Progress in lipid research, 48 5
-
J. Harris, F. Benedict (2010)
A biometric study of basal metabolism in man -
Yunsheng Ma, B. Olendzki, A. Hafner, D. Chiriboga, A. Culver, Victoria Andersen, P. Merriam, S. Pagoto (2006)
Low-carbohydrate and high-fat intake among adult patients with poorly controlled type 2 diabetes mellitus.Nutrition, 22 11-12
-
Qingguang Jiang, C.Y. Lee, Shweta Mandrekar, B. Wilkinson, P. Cramer, N. Zelcer, K. Mann, B. Lamb, T. Willson, Jon Collins, Jill Richardson, Jonathan Smith, T. Comery, D. Riddell, D. Holtzman, P. Tontonoz, G. Landreth (2008)
ApoE Promotes the Proteolytic Degradation of AβNeuron, 58
-
Yian Gu, J. Nieves, Y. Stern, J. Luchsinger, N. Scarmeas (2010)
Food combination and Alzheimer disease risk: a protective diet.Archives of neurology, 67 6
-
E. Ingelsson, E. Schaefer, J. Contois, J. Mcnamara, L. Sullivan, M. Keyes, M. Pencina, C. Schoonmaker, P. Wilson, R. D'Agostino, R. Vasan (2007)
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.JAMA, 298 7
-
I. Martins, Tamar Berger, M. Sharman, G. Verdile, S. Fuller, R. Martins (2009)
Cholesterol metabolism and transport in the pathogenesis of Alzheimer’s diseaseJournal of Neurochemistry, 111
-
F. Panza, V. Frisardi, C. Capurso, B. Imbimbo, G. Vendemiale, A. Santamato, G. D’Onofrio, D. Seripa, Daniele Sancarlo, A. Pilotto, V. Solfrizzi (2010)
Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms.Journal of Alzheimer's disease : JAD, 21 3
-
Mark Fishel, G. Watson, T. Montine, Qin Wang, P. Green, J. Kulstad, D. Cook, E. Peskind, L. Baker, D. Goldgaber, Wei Nie, S. Asthana, S. Plymate, M. Schwartz, S. Craft (2005)
Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults.Archives of neurology, 62 10
-
E. Rivera, Alison Goldin, Noah Fulmer, Rosemarie Tavares, J. Wands, S. Monte (2005)
Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine.Journal of Alzheimer's disease : JAD, 8 3
-
S. Craft (2009)
The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged.Archives of neurology, 66 3
-
W. Banks, J. Jaspan, Weitao Huang, A. Kastin (1997)
Transport of Insulin Across the Blood-Brain Barrier: Saturability at Euglycemic Doses of InsulinPeptides, 18
-
Mikio Shoji, M. Kanai, E. Matsubara, Y. Tomidokoro, M. Shizuka, Yoshio Ikeda, Masaki Ikeda, Y. Harigaya, Koichi Okamoto, Shunsaku Hirai (2001)
The levels of cerebrospinal fluid Aβ40 and Aβ42(43) are regulated age-dependentlyNeurobiology of Aging, 22
-
R. Takechi, S. Galloway, M. Pallebage-Gamarallage, V. Lam, J. Mamo (2010)
Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk.Progress in lipid research, 49 2
-
Stephanie Cosentino, Y. Stern, Elisaveta Sokolov, N. Scarmeas, J. Manly, M. Tang, N. Schupf, R. Mayeux (2010)
Plasma ß-amyloid and cognitive decline.Archives of neurology, 67 12
-
M. Pappolla, Tara Bryant‐Thomas, D. Herbert, Javier Pacheco, M. Garcia, M. Manjon, X. Gironés, Tracey Henry, E. Matsubara, D. Zambón, B. Wolozin, M. Sano, F. cruz-Sánchez, L. Thal, S. Petanceska, L. Refolo (2003)
Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathologyNeurology, 61
-
C. Sánchez-Moreno, Suzanne Dorfman, A. Lichtenstein, Antonio Martín (2004)
Dietary fat type affects vitamins C and E and biomarkers of oxidative status in peripheral and brain tissues of golden Syrian hamsters.The Journal of nutrition, 134 3
-
T. Kawarabayashi, L. Younkin, T. Saido, M. Shoji, K. Ashe, S. Younkin (2001)
Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's DiseaseThe Journal of Neuroscience, 21
- Publisher
- American Medical Association
- Copyright
- Copyright 2011 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
- ISSN
- 2168-6149
- eISSN
- 2168-6157
- DOI
- 10.1001/archneurol.2011.125
- pmid
- 21670398
- Publisher site
- See Article on Publisher Site
Abstract
ORIGINAL CONTRIBUTION Diet Intervention and Cerebrospinal Fluid Biomarkers in Amnestic Mild Cognitive Impairment Jennifer L. Bayer-Carter, MS; Pattie S. Green, PhD; Thomas J. Montine, MD, PhD; Brian VanFossen, PhD; Laura D. Baker, PhD; G. Stennis Watson, PhD; Laura M. Bonner, PhD; Maureen Callaghan, MD; James B. Leverenz, MD; Brooke K. Walter, MD; Elaine Tsai, MD; Stephen R. Plymate, MD; Nadia Postupna, PhD; Charles W. Wilkinson, PhD; Jing Zhang, PhD; Johanna Lampe, PhD; Steven E. Kahn, MB, ChB; Suzanne Craft, PhD Objective: To compare the effects of a 4-week high– isoprostanes, and apolipoprotein E, plasma lipids and in- saturated fat/high–glycemic index (HIGH) diet with a low– sulin, and measures of cognition. saturated fat/low–glycemic index (LOW) diet on insulin and lipid metabolism, cerebrospinal fluid (CSF) markers Results: For the aMCI group, the LOW diet increased of Alzheimer disease, and cognition for healthy adults and CSF A42 concentrations, contrary to the pathologic pat- adults with amnestic mild cognitive impairment (aMCI). tern of lowered CSF A42 typically observed in Alzhei- mer disease. The LOW diet had the opposite effect for Design: Randomized controlled trial. healthy adults, ie, decreasing CSF A42, whereas the HIGH diet increased CSF A42. The CSF apolipopro- Setting: Veterans Affairs
Journal
JAMA Neurology – American Medical Association
Published: Jun 1, 2011